Zhang Xintong, Han Ying, Huang Wei, Jin Mingji, Gao Zhonggao
State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Pharmaceutics, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Acta Pharm Sin B. 2021 Jul;11(7):1789-1812. doi: 10.1016/j.apsb.2020.09.013. Epub 2020 Sep 28.
Due to its safety, convenience, low cost and good compliance, oral administration attracts lots of attention. However, the efficacy of many oral drugs is limited to their unsatisfactory bioavailability in the gastrointestinal tract. One of the critical and most overlooked factors is the symbiotic gut microbiota that can modulate the bioavailability of oral drugs by participating in the biotransformation of oral drugs, influencing the drug transport process and altering some gastrointestinal properties. In this review, we summarized the existing research investigating the possible relationship between the gut microbiota and the bioavailability of oral drugs, which may provide great ideas and useful instructions for the design of novel drug delivery systems or the achievement of personalized medicine.
由于其安全性、便利性、低成本和良好的依从性,口服给药备受关注。然而,许多口服药物的疗效受到其在胃肠道中不理想的生物利用度的限制。一个关键且最容易被忽视的因素是共生肠道微生物群,它可以通过参与口服药物的生物转化、影响药物转运过程和改变一些胃肠道特性来调节口服药物的生物利用度。在本综述中,我们总结了现有研究,探讨肠道微生物群与口服药物生物利用度之间的可能关系,这可能为新型药物递送系统的设计或个性化医疗的实现提供重要思路和有用指导。